Paediatric Haematology and Oncology

Doç. Dr. Fatma Demir Yenigürbüz

Doctor and researcher Medicana International Istanbul - Beylikdüzü İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medicana.com.tr.

  • Kök Hücre Transplantasyonu
  • Lösemi
  • Lenfoma
  • Kemik İliği Yetmezliği (Doğuştan ve Edinsel)

CV

Education and experience

From source

Experience

  • 2018Şanlıurfa Eğitim ve Araştırma Hastanesi, Çocuk Hematoonkoloji Bölümü (Zorunlu Hizmet)medicana.com.tr
  • 2025Acıbadem Altunizade Hastanesi, Pediatrik Kök Hücre Transplantasyonu Bölümümedicana.com.tr

Education

  • 2005İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Türkçe Tıp Bölümümedicana.com.tr
  • 2011Okmeydanı Eğitim ve Araştırma Hastanesi, Çocuk Sağlığı ve Hastalıkları Bölümümedicana.com.tr
  • 2016Dokuz Eylül Üniversitesi Tıp Fakültesi, Çocuk Hematoonkolojisi Bilim Dalımedicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPaediatric Haematology and Oncologymedicana.com.trFrom source
  • InstitutionMedicana International Istanbul - Beylikdüzümedicana.com.trFrom source
  • Publications22 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:25https://www.medicana.com.tr/hekim-detay/25372/fatma-demir-yenigurbuzmedicana.com.tr

Scientific work

Publications

22 publications

  1. Tüfekçi Ö, Ören H, Demir Yenigürbüz F, Gözmen S, Karapınar TH, İrken G. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features. Turk J Haematol. 2015;32(2):175-179.

    Source: medicana.com.tr profile page

  2. Tüfekçi Ö, Yılmaz Bengoa Ş, Demir Yenigürbüz F, Şimşek E, Karapınar TH, İrken G, Ören H. Management of Invasive Fungal Infections in Pediatric Acute Leukemia and the Appropriate Time for Restarting Chemotherapy. Turk J Haematol. 2015;32(4):329-337.

    Source: medicana.com.tr profile page

  3. Yılmaz Bengoa Ş, Ataseven E, Kızmazoğlu D, Demir Yenigürbüz F, Erdem M, Ören H. FLAG Regimen with or without Idarubicin in Children with Relapsed/Refractory Acute Leukemia: Experience from a Turkish Pediatric Hematology Center. Turk J Haematol. 2017;34(1):46-51.

    Source: medicana.com.tr profile page

  4. Demir Yenigürbüz F, Ören H. Pediatric Deep Venous Thrombosis and Pulmonary Embolism: Can It Be Antiphospholipid Syndrome? Turk J Haematol. 2019;36(3):205-206.

    Source: medicana.com.tr profile page

  5. Demir Yenigürbüz F, Deveci U, Tuncez E. Peutz-Jeghers Syndrome: A Very Rare Cause of Iron Deficiency Anemia. Turk J Haematol. 2019;36(1):50-51.

    Source: medicana.com.tr profile page

  6. Kızmazoğlu D, Sarı S, Evim Sezgin M, Kantarcıoğlu A, Tüfekçi Ö, Demir Yenigürbüz F, Baytan B, Yılmaz Ş, Güneş AM, Ören H. Assessment of Health-Related Quality of Life in Pediatric Acute Lymphoblastic Leukemia Survivors: Perceptions of Children, Siblings, and Parents. Turk J Haematol. 2019;36(2):112-116.

    Source: medicana.com.tr profile page

  7. Yenigürbüz FD, Kızmazoğlu D, Ateş H, Erdem M, Tüfekçi Ö, Yılmaz Ş, Ören H. Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy. Blood Coagul Fibrinolysis. 2019;30(4):149-155.

    Source: medicana.com.tr profile page

  8. Yazal Erdem A, Demir Yenigürbüz F, Pekpak E, Akıncı B, Aktekin E, Bayram C, Yıldırmak ZY, Ataseven E, Akbayram S, Şaşmaz İ, Taburoğlu Yılmaz B, Özkan A, Akpınar Tekgündüz S, Köse D, Karapınar T, Büyükavcı M, Sal E, Bayhan T, Kirkiz S, Ünal Ş, Vergin RC, Çil M, Malbora B, Ayçiçek A, Yaralı HN, Özbek NY. Refugee children with beta-thalassemia in Turkey: Overview of demographic, socioeconomic, and medical characteristics. Pediatr Blood Cancer. 2019;66(5):e27636.

    Source: medicana.com.tr profile page

  9. Akçay A, Atay D, Erbey F, Akıncı B, Demir Yenigürbüz F, Eyüboğlu F, Ovalı E, Öztürk G. Safety and Efficacy of Co-transplantation of Hematopoietic Stem Cells Combined With Human Umbilical Cord-Derived Mesenchymal Stem Cells in Children With Severe Aplastic Anemia: A Single-Center Experience. Exp Clin Transplant. 2021.

    Source: medicana.com.tr profile page

  10. Atay D, Akçay A, Yenigürbüz FD, Akinci B, Bagirova K, Hasanova S, Öztürk G. Clinical study of graft-versus-host disease prophylaxis in unrelated hematopoietic stem cell transplantation for pediatric nonmalignant diseases with different doses anti-human T-lymphocyte immunoglobulin. Pediatr Transplant. 2021;25(8):e14098.

    Source: medicana.com.tr profile page

View all 22 publications